Publicly Traded Life Sciences Companies in the United States Are an Increasingly Popular Target of Securities Fraud Class Action Lawsuits -
The past year was particularly noteworthy with respect to the relative number...more
3/19/2015
/ Biotechnology ,
Class Action ,
Compliance ,
Disclosure Requirements ,
Insider Trading ,
Life Sciences ,
Medical Devices ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Publicly-Traded Companies ,
Rule 10b-5 ,
Securities Fraud ,
Surveys